Cellectis (CLLS) Change in Intangibles (2015 - 2025)

Cellectis (CLLS) recorded quarterly Change in Intangibles of -$1.2 million in Q3 2025, down 4050.0% quarter-over-quarter from -$28000.0 in Q3 2024, and down 4050.0% on a YoY basis from $29417.7 in Q3 2024.

Cellectis (CLLS) Change in Intangibles (2015 - 2025) Analysis & Trends

Cellectis' Change in Intangibles history runs 10 years deep, the most recent figure standing at -$1.2 million for Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.96 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Cellectis 17.40 Bn 17.21 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -1.16 Mn
Sep 30, 2025 -1.16 Mn
Sep 30, 2024 -28,000.00
Sep 30, 2024 -28,000.00
Mar 31, 2024 -37,000.00
Mar 31, 2024 -37,000.00
Sep 30, 2022 -163,000.00
Sep 30, 2022 -163,000.00
Sep 30, 2021 -857,000.00
Sep 30, 2021 -857,000.00
Jun 30, 2021 -1,000.00
Jun 30, 2021 -1,000.00
Mar 31, 2021 -22,000.00
Mar 31, 2021 -22,000.00
Sep 30, 2020 -2,000.00
Sep 30, 2020 -2,000.00
Jun 30, 2020 2,000.00
Jun 30, 2020 2,000.00
Mar 31, 2020 -43,000.00
Mar 31, 2020 -43,000.00